Point72 Hong Kong LTD Zoetis Inc. Call Options Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $14,829 - $18,255	-100 Reduced 3.03%	3,200 $475,000
Q2 2022 Aug 15, 2022	SELL	$155.97 - $200.09 $311,940 - $400,180	-2,000 Reduced 37.74%	3,300 $567,000
Q1 2022 May 16, 2022	BUY	$181.39 - $234.03 $344,641 - $444,657	1,900 Added 55.88%	5,300 $1 Million
Q4 2021 Feb 14, 2022	SELL	$193.69 - $247.03 $1.3 Million - $1.66 Million	-6,700 Reduced 66.34%	3,400 $830,000
Q3 2021 Nov 15, 2021	SELL	$189.29 - $209.69 $1.12 Million - $1.24 Million	-5,900 Reduced 36.88%	10,100 $1.96 Million
Q2 2021 Aug 16, 2021	SELL	$155.9 - $187.99 $670,370 - $808,357	-4,300 Reduced 21.18%	16,000 $2.98 Million
Q1 2021 May 17, 2021	BUY	$144.0 - $169.39 $2.58 Million - $3.03 Million	17,900 Added 745.83%	20,300 $3.2 Million
Q4 2020 Feb 16, 2021	BUY	$157.07 - $174.35 $376,968 - $418,440	2,400 New	2,400 $397,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.